Healing From Within
for your YOUNG CHILD

DUPIXENT in combination with a topical corticosteroid was studied in a 16-week clinical trial in 162
patients ages 6 months to 5 years with moderate-to-severe eczema not adequately controlled with topical
prescription treatments.

 

Dupixent results
in young children

From a clinical trial at 16 weeks (DUPIXENT + topical corticosteroids [TCS] vs TCS only):

7X
SAW CLEAR OR
ALMOST CLEAR SKIN

28% on DUPIXENT + TCS
vs 4% on TCS only

~5X
HAD LESS ITCH

48% on DUPIXENT + TCS
vs 9% on TCS only

≥75%
Clearer skin in
half
of young
children

53% on DUPIXENT + TCS vs 11% on TCS only

View BEFORE AND AFTER
Photos IN YOUNG CHILDREN

 

Click and drag
to see results

Before and after results of an actual 4-year-old patient after 16 weeks of treatment with DUPIXENT and a topical steroid in a phase 3 clinical trial. This patient met clinical trial criteria for clear or almost clear skin. Individual results may vary.

LONG-TERM SAFETY
RESULTS IN YOUNG CHILDREN

Long-term safety results in young children continuing on DUPIXENT with or without TCS in the pediatric extension study through 1 year were consistent with the adult clinical trials. In addition, hand-foot-and-mouth disease and warts were reported. In these reported cases, patients continued treatment with DUPIXENT.

MOST COMMON SIDE
EFFECTS INCLUDE:

  • Injection site reactions
  • Eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision
  • Dry eye
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

View the possible side effects of DUPIXENT

What You Should Know About the Patients in These Studies:

100%
Had severe
atopic dermatitis
~3.8 years
Average age
~58%
Average body surface area involvement

Have you spoken to a dermatologist or allergist about DUPIXENT?

Go back

Great! Sign up for DUPIXENT MyWay®, our patient support program, to access program benefits and get one-on-one support every step of the way, including help with filling your first prescription.

Enroll in DUPIXENT MyWay

Finding the right eczema treatment starts with the right kind of conversation.

Hear From Patients About
Their Journey to DUPIXENT

Answer a few short questions about your eczema symptoms and treatment goals. We’ll turn it into a personalized guide you can use at your next visit.

Get Started

Working with a dermatologist or allergist can lead to a more accurate diagnosis and more impactful treatment for your eczema.

Find a Specialist Near Me
DID YOU KNOW?
DUPIXENT is the only FDA-approved biologic for treating uncontrolled
moderate-to-severe eczema in children as young as 6 months.